Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients with Hepatocellular Carcinoma

Gastroenterology

Volumn 150, Issue 4, 2016, Pages 998-1008

  Xue, Ruidong ^a   Li, Ruoyan ^a   Guo, Hua ^b   Guo, Lin ^b   Su, Zhe ^a   Ni, Xiaohui ^a,c   Qi, Lisha ^b   Zhang, Ti ^b   Li, Qiang ^b   Zhang, Zemin ^a   Xie, Xiaoliang Sunney ^a,c   Bai, Fan ^a   Zhang, Ning ^b  

^a PEKING UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Liver Cancer; Metastasis; Pathogenesis; Spread

Indexed keywords

DNA; TUMOR MARKER;

ARTICLE; BILE DUCT CARCINOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CLONAL VARIATION; COMPARATIVE STUDY; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE COURSE; DNA ISOLATION; DNA LIBRARY; GENETIC HETEROGENEITY; GENOME ANALYSIS; GERMLINE MUTATION; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; NEXT GENERATION SEQUENCING; PHYLOGENETIC TREE; PRIORITY JOURNAL; SOMATIC MUTATION; UBIQUITINATION; CHINA; COMPLICATION; DNA MUTATIONAL ANALYSIS; EXOME; GENE DOSAGE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; LIVER TUMOR; MULTIPLE CANCER; MUTATION; PATHOLOGY; PHENOTYPE; PHYLOGENY; PREDICTIVE VALUE; PROGNOSIS; SECONDARY; VIROLOGY;

BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CHINA; DISEASE PROGRESSION; DNA COPY NUMBER VARIATIONS; DNA MUTATIONAL ANALYSIS; EXOME; GENE DOSAGE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEPATITIS B; HUMANS; LIVER NEOPLASMS; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; PHENOTYPE; PHYLOGENY; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84962892934     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.12.033     Document Type: Article

References (43)

1. Ferlay J SI, Ervik M, Dikshit R, et al. Incidence/mortality data. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr. Accessed: August 23, 2015.
2. F.S. Wang, J.G. Fan, Z. Zhang, and et al. The global burden of liver disease: the major impact of China Hepatology 60 2014 2099 2108
3. Z. Zhang Genomic landscape of liver cancer Nat Genet 44 2012 1075 1077
4. N. Portolani, A. Coniglio, S. Ghidoni, and et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications Ann Surg 243 2006 229 235
5. Y. Kishi, K. Hasegawa, Y. Sugawara, and et al. Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection Int J Hepatol 2011 2011 728103
6. R.T.-P. Poon, S.T. Fan, C.M. Lo, and et al. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation Ann Surg 235 2002 373 382
7. A. Fujimoto, Y. Totoki, T. Abe, and et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators Nat Genet 44 2012 760 764
8. Y. Tao, J. Ruan, S.H. Yeh, X. Lu, Y. Wang, W. Zhai, J. Cai, and et al. Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data Proc Natl Acad Sci U S A 108 2011 12042 12047
9. J. Huang, Q. Deng, Q. Wang, and et al. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma Nat Genet 44 2012 1117 1121
10. R. Miao, H. Luo, H. Zhou, and et al. Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis J Hepatol 61 2014 840 849
11. S. Jhunjhunwala, Z. Jiang, E.W. Stawiski, and et al. Diverse modes of genomic alteration in hepatocellular carcinoma Genome Biol 15 2014 436
12. J.U. Marquardt, D. Seo, J.B. Andersen, and et al. Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits J Hepatol 60 2014 346 353
13. M. Gerlinger, A.J. Rowan, S. Horswell, and et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing N Engl J Med 366 2012 883 892
14. N. Navin, J. Kendall, J. Troge, and et al. Tumour evolution inferred by single-cell sequencing Nature 472 2011 90 94
15. Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, et al, Swanton C. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing. Nat Genet 2014;46:225-233.
16. E.C. de Bruin, N. McGranahan, R. Mitter, M. Salm, D.C. Wedge, and et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution Science 346 2014 251 256
17. J. Zhang, J. Fujimoto, J. Zhang, and et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing Science 346 2014 256 259
18. G. Gundem, P. Van Loo, B. Kremeyer, and et al. The evolutionary history of lethal metastatic prostate cancer Nature 520 2015 353 357
19. O. Nakashima, and M. Kojiro Recurrence of hepatocellular carcinoma: multicentric occurrence or intrahepatic metastasis? A viewpoint in terms of pathology J Hepatobiliary Pancreat Surg 8 2001 404 409
20. R.T. Poon, S.T. Fan, I.O. Ng, and et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma Cancer 89 2000 500 507
21. M. Shi, C.Q. Zhang, Y.Q. Zhang, and et al. Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin World J Surg 28 2004 376 381
22. T. Okusaka, S. Okada, H. Ueno, and et al. Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features Cancer 95 2002 1931 1937
23. L.B. Alexandrov, S. Nik-Zainal, D.C. Wedge, and et al. Signatures of mutational processes in human cancer Nature 500 2013 415 421
24. S.L. Poon, S.T. Pang, J.R. McPherson, and et al. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool Sci Transl Med 5 2013 197ra101
25. A. Arzumanyan, H.M. Reis, and M.A. Feitelson Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma Nat Rev Cancer 13 2013 123 135
26. S.S. Thorgeirsson, and J.W. Grisham Molecular pathogenesis of human hepatocellular carcinoma Nat Genet 31 2002 339 346
27. P. Moinzadeh, K. Breuhahn, H. Stutzer, and et al. Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade-results of an explorative CGH meta-analysis Br J Cancer 92 2005 935 941
28. M.A. Patil, I. Gutgemann, J. Zhang, and et al. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma Carcinogenesis 26 2005 2050 2057
29. T. Shinagawa, M. Ohto, K. Kimura, and et al. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography. A study in 51 patients Gastroenterology 86 1984 495 502
30. X.D. Zhou, Z.Y. Tang, B.H. Yang, and et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma Cancer 91 2001 1479 1486
31. X. Ni, M. Zhuo, Z. Su, J. Duan, Y. Gao, Z. Wang, C. Zong, and et al. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients Proc Natl Acad Sci U S A 110 2013 21083 21088
32. A. Besaratinia, S.I. Kim, P. Hainaut, and et al. In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure Gastroenterology 137 2009 1127 1137 1137 e1-5
33. C.K. Ong, C. Subimerb, C. Pairojkul, and et al. Exome sequencing of liver fluke-associated cholangiocarcinoma Nat Genet 44 2012 690 693
34. W. Chan-On, M.L. Nairismagi, C.K. Ong, W.K. Lim, and et al. Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers Nat Genet 45 2013 1474 1478
35. S.-I. Ariizumi, Y. Kotera, S. Katagiri, and et al. Combined hepatocellular-cholangiocarcinoma had poor outcomes after hepatectomy regardless of Allen and Lisa class or the predominance of intrahepatic cholangiocarcinoma cells within the tumor Ann Surg Oncol 19 2012 1628 1636
36. R.A. Allen, and J.R. Lisa Combined liver cell and bile duct carcinoma Am J Pathol 25 1949 647 655
37. Z.D. Goodman, K.G. Ishak, J.M. Langloss, and et al. Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study Cancer 55 1985 124 135
38. W.R. Jarnagin, S. Weber, S.K. Tickoo, and et al. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors Cancer 94 2002 2040 2046
39. Y. Yano, J. Yamamoto, T. Kosuge, and et al. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases Jpn J Clin Oncol 33 2003 283 287
40. S.H. Kim, Y.N. Park, J.H. Lim, and et al. Characteristics of combined hepatocellular-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma Eur J Surg Oncol 40 2014 976 981
41. T. Roskams Liver stem cells and their implication in hepatocellular and cholangiocarcinoma Oncogene 25 2006 3818 3822
42. F. Zhang, X.P. Chen, W. Zhang, and et al. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence Histopathology 52 2008 224 232
43. S.B. Edge, and C.C. Compton The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM Ann Surg Oncol 17 2010 1471 1474